ARQT FY 2023 Earnings — Arcutis Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ARQTArcutis Biotherapeutics, Inc.

$3B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$60M+1517.1% YoY

Gross Profit

$55M91.6% margin

Operating Income

-$241M-404.5% margin

Net Income

-$262M-439.8% margin

EPS (Diluted)

$-3.78

Cash Flow

Operating Cash Flow

-$247M

Free Cash Flow

-$247M

Stock-Based Comp.

$39M

Balance Sheet

Total Assets

$341M

Total Liabilities

$253M

Stockholders' Equity

$89M

Cash & Equivalents

$88M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$60M	$4M	+1517.1%
Gross Profit	$55M	$3M	+1762.9%
Operating Income	-$241M	-$302M	+20.1%
Net Income	-$262M	-$311M	+15.8%